Fortis Healthcare Approves FY26 Audited Results, Recommends Final Dividend

Fortis Healthcare Limited's Board of Directors has approved the audited financial results for the fiscal year ended March 31, 2026. The board also recommended a final dividend of ₹1 per equity share.

Financial Year Closure and Dividend Proposal

On May 22, 2026, the Board of Directors of Fortis Healthcare Limited met to approve the company's audited financial results for the fiscal year ending March 31, 2026. Both standalone and consolidated financial statements received board approval. Additionally, the board recommended a final dividend of ₹1 per equity share, representing 10% of the face value, for the 2025-26 financial year. This dividend proposal is subject to the approval of shareholders at the upcoming Annual General Meeting (AGM).

Significance of the Approvals

The approval of audited financials formally closes the fiscal year's financial reporting and confirms regulatory compliance. The recommended dividend signals Fortis Healthcare's intention to distribute profits to its shareholders, potentially enhancing shareholder value. However, the actual payout is contingent on shareholder approval.

About Fortis Healthcare

Fortis Healthcare is a leading integrated healthcare services provider in India, operating a network of hospitals and offering a range of medical services. The financial year 2025-26 provides a comprehensive view of its financial performance.

Next Steps for Shareholders

Shareholders will consider and vote on the proposed final dividend at the AGM. If shareholder approval is obtained, the company will proceed with dividend distribution. The audited financial results will be made public, providing investors with insights into the company's financial health.

Shareholder Approval Risk

The primary risk to consider is that the dividend payment is subject to shareholder approval, which may not be granted. Investors should monitor the outcome of the shareholder vote.

Key Metrics

• Financial Year Ended: March 31, 2026
• Board Meeting Date: May 22, 2026
• Recommended Final Dividend: ₹1 per equity share